Darunavir/ritonavir
Sponsors
Germans Trias i Pujol Hospital, French National Agency for Research on AIDS and Viral Hepatitis, St Stephens Aids Trust, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, University of California, San Francisco
Conditions
AIDSHIVHIV InfectionHIV InfectionsHIV-1 Adults PatientsHIV-1 InfectionHIV-1 InfectionsHIV-infection
Phase 1
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
CompletedNCT00307502
Start: 2005-01-31End: 2009-12-31Updated: 2019-12-04
Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
CompletedNCT00765271
Start: 2008-05-31End: 2008-10-31Updated: 2009-11-18
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
CompletedNCT00877591
Start: 2008-04-30End: 2013-04-30Updated: 2014-05-06
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
CompletedNCT00920088
Start: 2009-06-30End: 2009-11-30Updated: 2010-11-03
Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
CompletedNCT01876966
Start: 2011-03-31End: 2011-07-31Updated: 2013-06-13
Phase 2
Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
CompletedNCT00460382
Start: 2007-05-31End: 2009-09-30Updated: 2010-09-17
Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults
CompletedNCT00830804
Start: 2009-04-30End: 2010-09-30Updated: 2018-11-08
Phase 4
Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
CompletedNCT00994344
Start: 2009-10-31End: 2012-10-31Updated: 2014-02-13
Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients
NCT01013987
Start: 2010-02-28Target: 60Updated: 2010-02-10
Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject
CompletedNCT02159599
Start: 2014-07-31End: 2016-04-30Updated: 2017-02-14
Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects
CompletedNCT02770508
Start: 2015-11-30End: 2017-10-31Updated: 2018-08-03
Unknown Phase
Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
CompletedNCT01606722
Start: 2010-01-31End: 2013-06-30Updated: 2013-07-11
Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS
Active, not recruitingPACTR201409000836146
Start: 2014-05-05Target: 150Updated: 2026-01-27